The pharmaceutical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a exciting breakthrough. Unlike subcutaneous injections, this approach offers a more convenient way to administer https://lawsonfymj080795.life3dblog.com/39450753/glp-1-patches-a-new-approach-to-blood-sugar-treatment